|Home||» Products||» Pharmaceutical Formulations||» Bortezomib Injection 3.5 mg|
We standout amid the pertinent providers of Bortezomib Injection 3.5 mg. Through the assistance of our masters, we effectively formulate the medicines utilizing superior class compounds, procured from the certified vendors. The customers can obtain our medicines in distinctive quantity packing alternatives. To offer a defect free array to the customers, we inspect our bortezomib injection on specified quality grounds to make sure that only flawless gamut is offered to the customers at affordable prices.
Amount of Dose :-
Amount of medication in before uncured multiple myeloma.
Our injection bortezomib is prescribed as a 3-5 second remedy IV injection in mix with oral prednisone and melphalan two months to two and half months therapy course as appeared in Table 1. In Series 1-4, EGYBORT is directed twice in a week (days counted as 1, 4, 8, 11, 22, 25, 29 and lastly, 32). In Series 5-9, EGYBORT is directed once in a week (days directed as 1, 8, 22 and 29). No less than 72 hours ought to pass between consecutive dosages of EGYBORT.
Packing: 1 container of 2mg
We additionally provide:
Our business, which is based in Delhi is a prevalent provider of Bortezomib Injections. These injections that we formulate accessible are demonstrated if there should arise an occurrence of Mantle cell lymphoma and Multiple myeloma. We guarantee that the Injections arrives the purchasers in magnificent quality packing alternatives. Large quantity orders of our Injections are prepared by us according to the particular prerequisites of the purchasers.
Mantle cell lymphoma
Dosage in Previously Untreated Multiple Myeloma : Bortezomib is administered as a 3-5 second bolus IV injection in combination with oral melphalan and oral prednisone for nine 6-week treatment cycles as shown in Table 1. In Cycles 1-4, Bortezomib is administered twice weekly (days 1, 4, 8, 11, 22, 25, 29 and 32). In Cycles 5-9, Bortezomib is administered once weekly (days 1, 8, 22 and 29). At least 72 hours should elapse between consecutive doses of Bortezomib.
Measurement of doses in Relapsed Mantle Cell Lymphoma and Multiple Myeloma: our injection (1.3mg/m²/dosage) is directed in the form of 3-5 second pill IV injection two times in a week, which should be continued to two weeks (Days counted as 1, 4, 8 and 11) ensued by a 10-day break period (Days from 12-21). For expanded treatment of exceeding 8 cycles, Bortezomib might be managed on the standard plan or on an upkeep timetable of once a week for one month (Times in respect of days 1, 8, 15, and 22) ensued by a 13-day break session (from day 23 to 35). No less than 72 hours should to pass between serial dosages of our injection.
VEA IMPEX All Rights Reserved.